Amphetamine-dextroamphetamine is a prescription stimulant medication used primarily to treat attention deficit hyperactivity disorder (ADHD). You probably know it by its most common brand name, Adderall. The drug contains a specific blend of amphetamine salts in a 3:1 ratio of dextroamphetamine to levoamphetamine, two closely related compounds that work together to improve focus, attention, and impulse control. It is also sometimes prescribed for narcolepsy, a condition that causes uncontrollable daytime sleepiness.
How It Works in the Brain
Amphetamine-dextroamphetamine increases the levels of two chemical messengers in the brain: dopamine and norepinephrine. It does this in two ways. First, it triggers nerve cells to release more of these chemicals into the spaces between neurons. Second, it blocks those neurons from reabsorbing the chemicals back in, so they stay active longer.
Dopamine plays a central role in motivation, reward, and the ability to sustain attention. Norepinephrine helps with alertness and the ability to respond to tasks. In people with ADHD, these signaling systems are often underactive. By boosting both chemicals simultaneously, the medication helps the brain’s attention and self-regulation circuits function more effectively. The “dextro” form (d-amphetamine) is generally considered the more potent of the two at stimulating these pathways, which is why the formulation leans heavier toward it.
Immediate-Release vs. Extended-Release
The medication comes in two main formulations. Immediate-release (IR) tablets reach peak levels in the bloodstream in about 3 hours and typically wear off after 4 to 6 hours, which means most people take them twice a day. Extended-release (XR) capsules are designed for once-daily dosing, reaching peak levels around 7 hours after you take them. A single 20 mg XR capsule delivers roughly the same total exposure as two 10 mg IR tablets taken 4 hours apart, just spread out more gradually.
The XR version contains two types of tiny beads inside each capsule: one set dissolves right away, and the other dissolves hours later. This creates a smoother, longer-lasting effect throughout the day without the need for a second dose, which can be especially practical for children in school or adults at work.
What It’s Prescribed For
The FDA has approved amphetamine-dextroamphetamine for ADHD in children ages 3 and older, adolescents, and adults. The immediate-release formulation is also approved for narcolepsy. For ADHD, the typical starting point varies by age. Children ages 6 to 12 usually begin on 10 mg once daily of the XR capsule, with adjustments made in 5 to 10 mg increments each week, up to a maximum of 30 mg per day. Adolescents ages 13 to 17 also typically start at 10 mg, with an option to increase to 20 mg after one week. Adults with ADHD commonly start at 20 mg per day.
Common Side Effects
The most frequently reported side effects tend to be related to the drug’s stimulant properties. These include:
- Appetite suppression and weight loss, which are among the most noticeable effects, especially early in treatment
- Dry mouth
- Headache
- Nervousness or restlessness
- Trouble sleeping, particularly if the medication is taken too late in the day
- Nausea, constipation, or diarrhea
In children and adolescents, the medication can slow growth and weight gain over time. Pediatricians typically monitor height and weight at regular intervals and may recommend periodic breaks from the medication (sometimes called “drug holidays”) to allow catch-up growth, though this is an individualized decision.
Serious Risks to Be Aware Of
The FDA’s most prominent safety warning on this medication is a boxed warning about abuse, misuse, and addiction. Amphetamine-dextroamphetamine has a high potential for abuse, and misuse can lead to overdose and death, particularly at high doses or when the drug is snorted or injected rather than taken orally as prescribed.
Cardiovascular risks are another significant concern. The medication raises heart rate and blood pressure, and in rare cases it has been associated with sudden death, heart attack, or stroke, particularly in people with pre-existing heart defects or serious heart conditions. Before starting treatment, your prescriber will typically ask about any personal or family history of heart problems, and some patients may need an electrocardiogram. Routine monitoring of blood pressure, heart rate, and any new symptoms like chest pain, fainting, or shortness of breath during exercise is standard throughout treatment.
Psychiatric side effects, while less common, can include new or worsening symptoms of depression, mania, hallucinations, or paranoia. These are more likely in people with a personal or family history of mental health conditions, but they can occasionally appear in people with no prior history.
Drug Interactions
The most dangerous interaction is with a class of older antidepressants called MAO inhibitors. Combining them with amphetamine-dextroamphetamine can cause a severe, potentially fatal spike in blood pressure. You should not take this medication within 14 days of using an MAO inhibitor.
Certain common antidepressants, including SSRIs like sertraline or fluoxetine, can interact with amphetamines to increase the risk of serotonin syndrome, a dangerous condition involving high fever, confusion, rapid heartbeat, and muscle rigidity. Many people do take an SSRI and a stimulant together safely, but it requires careful monitoring and often a lower starting dose.
Acidity matters too. Medications that reduce stomach acid, like proton pump inhibitors, can change how quickly the drug is absorbed. Highly acidic foods or drinks (like citrus juice) taken around the same time as the medication may reduce its effectiveness, while alkaline substances can increase absorption.
Legal Classification and Prescription Rules
Amphetamine-dextroamphetamine is classified as a Schedule II controlled substance by the DEA, the same category as oxycodone and fentanyl. This means prescriptions cannot be called in to a pharmacy over the phone in most states. Refills are not allowed on the same prescription. You need a new prescription each time, and in many states, the prescription expires after a set period (often 90 days) if not filled. These restrictions exist because of the medication’s high potential for abuse and dependence.
Supply Shortages
Since late 2022, amphetamine-dextroamphetamine has experienced significant and recurring supply shortages across the United States. The causes have included increased demand, manufacturing delays, and DEA production quotas that limit how much of the active ingredient manufacturers can produce each year. While the FDA has been working with manufacturers to resolve these disruptions, availability has remained inconsistent for many patients. If your pharmacy is out of stock, checking with other nearby pharmacies, asking about different manufacturers’ versions of the generic, or discussing alternative formulations with your prescriber are practical steps.